• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,010
83
63
60
46

COUNTRY

58
19
10
7
5

CATEGORIES

  • 85
  • 124
  • 66
  • 65
  • 37
  • 37
  • 12
  • 12
  • 11
  • 18

PRICE

143
607
1,009
2,730

PUBLISHED

7
75
620
2,730

PRODUCT TYPE

2,619
91
12
7
1

Oncology

(2,730 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Gastrointestinal Tumor - Pipeline Review, H2 2013

Gastrointestinal Tumor - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Gastrointestinal Tumor - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013', provides an overview of...

October 2013
FROM

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013', provides an overview of the indication’s...

October 2013
FROM

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2013

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2013', provides an overview of the indication’s...

October 2013
FROM

Metastatic Ovarian Cancer - Pipeline Review, H2 2013

Metastatic Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Ovarian Cancer - Pipeline Review, H2 2013

Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

T-Cell Lymphomas - Pipeline Review, H2 2013

T-Cell Lymphomas - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'T-Cell Lymphomas - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Osteosarcoma - Pipeline Review, H2 2013

Osteosarcoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Osteosarcoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2013

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2013', provides an overview of...

October 2013
FROM

Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2013

Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Breast Cancer - Pipeline Review, H2 2013

Breast Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Breast Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Sarcomas - Pipeline Review, H2 2013

Sarcomas - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Sarcomas - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

October 2013
FROM

Kidney Cancer - Pipeline Review, H2 2013

Kidney Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Kidney Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Squamous Cell Carcinoma - Pipeline Review, H2 2013

Squamous Cell Carcinoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Squamous Cell Carcinoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Lung Cancer - Pipeline Review, H2 2013

Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Indolent Lymphoma - Pipeline Review, H2 2013

Indolent Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Indolent Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Hairy Cell Leukemia - Pipeline Review, H2 2013

Hairy Cell Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hairy Cell Leukemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

October 2013
FROM

Metastatic Lung Cancer - Pipeline Review, H2 2013

Metastatic Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2013

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2013',...

October 2013
FROM

Glioma - Pipeline Review, H2 2013

Glioma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Glioma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

October 2013
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)